Breast Cancer Redox Heterogeneity Detectable with Chemical Exchange Saturation Transfer (CEST) MRI

Molecular Imaging and Biology

Volumn 16, Issue 5, 2014, Pages 670-679

  Cai, Kejia ^a,b   Xu, He N ^b,c   Singh, Anup ^b,e   Moon, Lily ^b,c   Haris, Mohammad ^b,d   Reddy, Ravinder ^b   Li, Lin Z ^b,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^e INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Cancer metabolism; CEST; Intratumor heterogeneity; NADH; Redox state

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL; BREAST NEOPLASMS; FEMALE; HUMAN; MCF 7 CELL LINE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; OXIDATION REDUCTION REACTION; PROCEDURES;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MCF-7 CELLS; MICE, NUDE; NAD; OXIDATION-REDUCTION;

EID: 84939878067     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-014-0739-y     Document Type: Article

References (48)

1. Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651–2660
2. Kumar R, Kuniyasu H, Bucana CD et al (1998) Spatial and temporal expression of angiogenic molecules during tumor growth and progression. Oncol Res 10:301–311
3. Eberhard A, Kahlert S, Goede V et al (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60:1388–1393
4. Picchio M, Beck R, Haubner R et al (2008) Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography. J Nucl Med 49:597–605
5. Gonzalez-Garcia I, Sole RV, Costa J (2002) Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci U S A 99:13085–13089
6. Schroeder T, Yuan H, Viglianti BL et al (2005) Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res 65:5163–5171
7. Li LZ, Zhou R, Xu HN et al (2009) Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A 106:6608–6613
8. Xu HN, Zheng G, Tchou J et al (2013) Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging. SpringerPlus 2:73
9. Xu HN, Tchou J, Li LZ (2013) Redox imaging of human breast cancer core biopsies: a preliminary investigation. Acad Radiol 20:764–768
10. Xu HN, Nioka S, Glickson JD et al (2010) Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J Biomed Opt 15:036010
11. Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892
12. Fidler IJ (1987) Review: biologic heterogeneity of cancer metastases. Breast Cancer Res Treat 9:17–26
13. Casanovas O, Hicklin DJ, Bergers G, Hanahan D (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8:299–309
14. Ying WH (2008) NAD(+)/ NADH and NADP(+)/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10:179–206
15. Orrenius S, Gogvadze A, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol 47:143–183
16. Li LZ (2012) Imaging mitochondrial redox potential and its possible link to tumor metastatic potential. J Bioenerg Biomembr 44:645–653
17. Quistorff B, Haselgrove JC, Chance B (1985) High spatial-resolution readout of 3-D metabolic organ structure—an automated, low-temperature redox ratio-scanning instrument. Anal Biochem 148:389–400
18. Li LZ, Zhou R, Zhong T et al (2007) Predicting melanoma metastatic potential by optical and magnetic resonance imaging. Adv Exp Med Biol 599:67–78
19. Xu HN, Nioka S, Li LZ (2013) Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res 1:6
20. Xu HN, Feng M, Moon L et al (2013) Redox imaging of the p53-dependent mitochondrial redox state in colon cancer ex vivo. J Innov Opt Health Sci 6(3):1350016
21. Ostrander JH, McMahon CM, Lem S et al (2010) Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Res 70:4759–4766
22. Walsh AJ, Cook RS, Manning HC et al (2013) Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res 73:6164–6174
23. Zhou JY, Tryggestad E, Wen ZB et al (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17:130–U308
24. van Zijl PC, Jones CK, Ren J et al (2007) MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 104:4359–4364
25. Ling W, Regatte RR, Navon G, Jerschow A (2008) Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci U S A 105:2266–2270
26. Haris M, Cai K, Singh A et al (2011) In vivo mapping of brain myo-inositol. Neuroimage 54:2079–2085
27. Cai K, Haris M, Singh A et al (2012) Magnetic resonance imaging of glutamate. Nat Med 18:302–306
28. Cai K, Xu HN, Singh A et al (2013) Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning. Adv Exp Med Biol 765:39–45
29. Cheng LL, Chang IW, Smith BL, Gonzalez RG (1998) Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 135:194–202
30. Sitter B, Sonnewald U, Spraul M et al (2002) High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15:327–337
31. Veech RL (2006) The determination of the redox states and phosphorylation potential in living tissues and their relationship to metabolic control of disease phenotypes. Biochem Mol Biol Educ: Bimon Publ Int Union Biochem Mol Biol 34:168–179
32. Haris M, Nanga RP, Singh A et al (2012) Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI. NMR Biomed 25:1305–1309
33. Zhou J, Tryggestad E, Wen Z et al (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17:130–134
34. Ameri K, Luong R, Zhang H et al (2010) Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br J Cancer 102:561–569
35. Xu HN, Zhou R, Nioka S et al (2009) Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials. Adv Exp Med Biol 645:247–253
36. Hensley CT, Wasti AT, DeBerardinis RJ (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 123:3678–3684
37. Kung H-N, Marks JR, Chi J-T (2011) Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet 7:e1002229
38. Cuperlovic-Culf M, Chute IC, Culf AS et al (2011) 1H NMR metabolomics combined with gene expression analysis for the determination of major metabolic differences between subtypes of breast cell lines. Chem Sci 2:2263–2270
39. Li LZ, Xu HN, Ranji M et al (2009) Mitochondrial redox imaging for cancer diagnostic and therapeutic studies. J Innov Opt Health Sci 2:325–341
40. Lemasters JJ, Nieminen AL (2001) Mitochondria in pathogenesis. Kluwer Academic/Plenum Publishers.
41. Boschi F, Marzola P, Sandri M et al (2008) Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-albumin and B-22956/1 in an experimental model of mammary carcinoma. MAGMA 21:169–176
42. Horas JA, Olguin OR, Rizzotto MG (2005) On the surviving fraction in irradiated multicellular tumour spheroids: calculation of overall radiosensitivity parameters, influence of hypoxia and volume effects. Phys Med Biol 50:1689–1701
43. Cao Y, Nagesh V, Hamstra D et al (2006) The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res 66:8912–8917
44. Liu G, Li Y, Sheth VR, Pagel MD (2012) Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. Mol Imaging 11:47–57
45. Bhujwalla ZM, Artemov D, Ballesteros P et al (2002) Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed 15:114–119
46. Cai K, Shore A, Singh A et al (2012) Blood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research. NMR Biomed 25:1125–1132
47. Winter PM, Schmieder AH, Caruthers SD et al (2008) Minute dosages of alpha(nu)beta(3)-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits. FASEB J 22:2758–2767
48. Jackson A, O’Connor JPB, Parker GJM, Jayson GC (2007) Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 13:3449–3459